Vagus Nerve Stimulation
Customize your policy alerts
Sign up for carolinabehavioralhealth Policy CP.MP.12 alerts
Get alerted when Policy CP.MP.12 changes without checking for updates manually.
Monitor payer policy activity
Coverage of implantable and transcutaneous vagus nerve stimulation for epilepsy, seizures, and other proposed indications. Implantable VNS may be medically necessary for medically refractory seizures meeting specified clinical criteria; other indications and transcutaneous approaches are not supported.
The criteria were revised to specify implantable vagus nerve stimulation and to add Lennox-Gastaut syndrome as an eligible condition.
Cluster headaches or migraines were added to the applicable clinical criteria.
Aspire SR Model 106 was removed as a medically necessary VNS option.
HCPCS code C1827 was added to the codes considered medically necessary or supportive of coverage criteria.
The ICD-10 diagnosis code table was removed from the policy.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.